Profluent

Profluent Bio provides an AI-driven platform for designing functional proteins and AI-designed gene editors for biomedicine and agriculture. It targets biotech and pharma R&D organizations, universities, and agricultural biotech researchers, offering partnerships and licensing of its AI models for drug discovery and crop improvement. The company differentiates itself with frontier AI models for de novo protein design (ProGen3) and AI-designed gene editors (OpenCRISPR), enabling faster design-validation cycles.